Log In
BCIQ
Print this Print this
 

PBT519

  Manage Alerts
Collapse Summary General Information
Company Prana Biotechnology Ltd.
DescriptionMetal protein-attenuating compound (MPAC)
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationBrain cancer
Indication DetailsTreat brain cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today